VBL Therapeutics is using its unique scientific platforms and drug development capabilities to address serious diseases including psoriasis, rheumatoid arthritis, thyroid cancer, brain cancer and many other diseases.

Several of our compounds are already in clinical trials at leading centers throughout the United States, Europe and Israel, while additional clinical trials in other disease areas are expected to begin in 2010.